Sr.no |
Title of project |
Name of faculty |
Ongoing/completed/in pipeline |
1. |
A prospective, multicentre, Open-label, Phase IV, Interventional study to assess the safety and efficacy of Capmatinib in Indian patients with Mesenchymal-Epithelial Transition (MET) exon 14 skipping Mutation Positive Advanced Non-small cell Lung Cancer (NSCLC)
|
Dr Vandana Singh Kushwaha (PI) Dr Ganesh Dakhle(Co PI) Dr Santha Kumar S. (Co PI) |
in pipeline |